AICAR is the other non-peptide small molecule in this batch and raises the same point from a different direction, being a nucleoside whose characterisation requirements are equally unlike a peptide's
its administered via injections or capsules in clinical settings.[4] It enhances fat burning, energy, insulin sensitivity, muscle preservation, and repair, while indirectly boosting NAD+ by slowing depletion.[5][23][24] Its membrane-permeable nature allows efficient cellular entry, making it suitable for therapeutic use
Yes, but separate applications
When to increase dose Consider increasing if: Minimal response after 4-6 weeks at current dose No side effects at current dose Current dose below the higher end of recommended range Goals not being met with conservative approach Increase gradually, typically by 25-50% at a time
If you are using oral capsules, you only need the capsules themselves no syringes or BAC water
Mice studies suggest that inhibiting NNMT stimulates stem cells and boosts muscle repair